Literature DB >> 28781685

Two serine residues of non-metastasis protein 23-H1 are critical in inhibiting signal transducer and activator of transcription 3 activity in human lung cancer cells.

Zhihao Wu1, Lili Guo2,3, Jiangnan Ge2, Zhijian Zhang2, Huijun Wei4, Qinghua Zhou2,5.   

Abstract

Constitutive activation of signal transducer and activator of transcription 3 (STAT3) in numerous cancers, including lung cancer, is one of the major mechanisms of tumor progression and metastasis. The authors previously reported that the metastasis suppressor non-metastasis protein 23-H1 (Nm23-H1) negatively regulates STAT3 activity by inhibiting its phosphorylation on Tyr705. Nm23-H1 is a multifunction protein that has three different kinase activities. By transfecting the five mutants that inactivated three different kinase activities respectively into Nm23-H1 deficient lung cancer cell lines, it was identified that Nm23-H1S44A (Ser44 to Ala) and Nm23-H1S120G (Ser120 to Gly) mutant forms were unable to suppress STAT3 phosphorylation on Tyr705, resulting in increased expression of fibronectin and matrix metalloproteinase-9. Notably, protein inhibitor of activated STAT3 was also involved in Nm23-H1S44A- and Nm23-H1S120G-mediated suppression of STAT3 phosphorylation. The present results indicated that Ser44 and Ser120 sites of Nm23-H1 may be responsible for its biological suppressive effects of STAT3 and tumor metastasis, which may contribute to illuminate the metastasis suppression function of Nm23-H1 in lung cancer.

Entities:  

Keywords:  metastasis; non-metastasis protein 23-H1; non-small-cell lung cancer; protein inhibitor of activated signal transducer and activator of transcription 3; signal transducer and activator of transcription 3

Year:  2017        PMID: 28781685      PMCID: PMC5530184          DOI: 10.3892/ol.2017.6363

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

Review 1.  Regulation of cytokine signaling pathways by PIAS proteins.

Authors:  Ke Shuai
Journal:  Cell Res       Date:  2006-02       Impact factor: 25.617

Review 2.  STAT3 signaling: anticancer strategies and challenges.

Authors:  Paul A Johnston; Jennifer R Grandis
Journal:  Mol Interv       Date:  2011-02

3.  Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis.

Authors:  P S Steeg; G Bevilacqua; R Pozzatti; L A Liotta; M E Sobel
Journal:  Cancer Res       Date:  1988-11-15       Impact factor: 12.701

4.  PIAS3 activates the intrinsic apoptotic pathway in non-small cell lung cancer cells independent of p53 status.

Authors:  Snehal Dabir; Amy Kluge; Karen McColl; Yu Liu; Minh Lam; Balazs Halmos; Gary Wildey; Afshin Dowlati
Journal:  Int J Cancer       Date:  2013-09-23       Impact factor: 7.396

5.  Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.

Authors:  Guilian Niu; Kenneth L Wright; Mei Huang; Lanxi Song; Eric Haura; James Turkson; Shumin Zhang; Tianhong Wang; Dominic Sinibaldi; Domenico Coppola; Richard Heller; Lee M Ellis; James Karras; Jacqueline Bromberg; Drew Pardoll; Richard Jove; Hua Yu
Journal:  Oncogene       Date:  2002-03-27       Impact factor: 9.867

6.  Metastasis suppressor Nm23-H1 inhibits STAT3 signaling via a negative feedback mechanism.

Authors:  Lei Gong; Zhihao Wu; Lili Guo; Lin Li; Rongzhi Zhao; Daxing Zhu; Qinghua Zhou
Journal:  Biochem Biophys Res Commun       Date:  2013-04-10       Impact factor: 3.575

7.  Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function.

Authors:  George Z Cheng; Wei Zhou Zhang; Mei Sun; Qi Wang; Domenico Coppola; Mena Mansour; Li Mei Xu; Carliann Costanzo; Jin Q Cheng; Lu-Hai Wang
Journal:  J Biol Chem       Date:  2008-03-19       Impact factor: 5.157

Review 8.  SOCS regulation of the JAK/STAT signalling pathway.

Authors:  Ben A Croker; Hiu Kiu; Sandra E Nicholson
Journal:  Semin Cell Dev Biol       Date:  2008-07-30       Impact factor: 7.727

9.  Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.

Authors:  Daoyan Wei; Xiangdong Le; Leizhen Zheng; Liwei Wang; Jennifer A Frey; Allen C Gao; Zhihai Peng; Suyun Huang; Henry Q Xiong; James L Abbruzzese; Keping Xie
Journal:  Oncogene       Date:  2003-01-23       Impact factor: 9.867

10.  PIAS3 expression in squamous cell lung cancer is low and predicts overall survival.

Authors:  Rime Abbas; Karen S McColl; Adam Kresak; Michael Yang; Yanwen Chen; Pingfu Fu; Gary Wildey; Afshin Dowlati
Journal:  Cancer Med       Date:  2015-01-09       Impact factor: 4.711

View more
  4 in total

Review 1.  The actions of NME1/NDPK-A and NME2/NDPK-B as protein kinases.

Authors:  Paul V Attwood; Richmond Muimo
Journal:  Lab Invest       Date:  2017-12-04       Impact factor: 5.662

2.  The Metastasis Suppressor Protein Nme1 Is a Concentration-Dependent Modulator of Ca2+/Calmodulin-Dependent Protein Kinase II.

Authors:  Leandro Royer; Kathryn Shangraw; Josiah J Herzog; Sandrine Pouvreau; Michael T Marr; Suzanne Paradis
Journal:  Biochemistry       Date:  2019-06-04       Impact factor: 3.162

3.  Systematic analysis of gene expression alterations and clinical outcomes of STAT3 in cancer.

Authors:  Xiangrong Cui; Xuan Jing; Qin Yi; Chunlan Long; Bin Tan; Xin Li; Xueni Chen; Yue Huang; Zhongping Xiang; Jie Tian; Jing Zhu
Journal:  Oncotarget       Date:  2017-12-14

Review 4.  [Roles of Histidine Kinases and Histidine Phosphatases in Cancer].

Authors:  Yafang Dong; Huimin Han; Yafeng Li; Lili Guo
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.